BMS/AbbVie where awarded Breakthrough status for Elotuzumab last night in combination through a Phase II completed last year although currently in Phase III. What's worth noting though is the NK cells in the above and observations made in analysis of patients own immune systems post SM6 trial.
Just saying......
- Forums
- ASX - By Stock
- PAB
- good for pab/sm6
good for pab/sm6, page-7
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
-0.003(50.0%) |
Mkt cap ! $6.172M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $84.66K | 23.80M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 30120630 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 19324482 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 29525630 | 0.003 |
29 | 36013999 | 0.002 |
13 | 44051998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 19324482 | 8 |
0.005 | 20861520 | 8 |
0.006 | 4171450 | 6 |
0.007 | 449941 | 2 |
0.008 | 1221910 | 4 |
Last trade - 15.09pm 02/10/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |